Francesca Sozio

Francesca Sozio

Auto-generated profile, based on publicly available information

Francesca Sozio

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2018 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
LTLaura Tiberio
Laura Tiberio
APAnnalisa Del Prete
Annalisa Del Prete
TSTiziana Schioppa
Tiziana Schioppa
FSFrancesca Sozio
Francesca Sozio
Daniela BosisioDaniela Bosisio
Daniela Bosisio
SSSilvano Sozzani
Silvano Sozzani

1 January 2017 in Journal of Hepatology
Verified
Journal Article
Closed access
CRChiara Raggi
Chiara Raggi
MCMargherita Correnti
Margherita Correnti
ASAntonio Sica
Antonio Sica
JAJesper B Andersen
Jesper B Andersen
VCVincenzo Cardinale
Vincenzo Cardinale
PIPietro Invernizzi
Pietro Invernizzi

7 September 2017 in Blood
Verified
Journal Article
Open access
PDF file
APANNALISA DEL PRETE
ANNALISA DEL PRETE
LMLaura Martínez Muñoz
Laura Martínez Muñoz
CMCristina Mazzon
Cristina Mazzon
LTLara Toffali
Lara Toffali
FSFrancesca Sozio
Francesca Sozio
SSSilvano Sozzani
Silvano Sozzani
Key Points: CCRL2 is required for CXCR2-dependent neutrophil recruitment. CCRL2 forms heterodimers with CXCR2 and regulates CXCR2 signaling.

26 May 2017 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
VSValentina Salvi
Valentina Salvi
FSFrancesca Sozio
Francesca Sozio
SSSilvano Sozzani
Silvano Sozzani
APAnnalisa Del Prete
Annalisa Del Prete
Inflammatory reactions occurring in the central nervous system (CNS), known as neuroinflammation, are key components of the pathogenic mechanisms underlying several neurological diseases. The chemokine system plays a crucial role in the recruitment and activation of immune and non-immune cells in the brain, as well as in the regulation of microglia phenotype and function. Chemokines belong to a heterogeneous family of chemotactic agonists that signal through the interaction with G protein-coupled receptors (GPCRs). Recently, a small subset of chemokine receptors, now identified as “atypical chemokine receptors” (ACKRs), has been described. These receptors lack classic GPCR signaling and chemotactic activity and are believed to limit inflammation through their ability to scavenge chemokines at the inflammatory sites. Recent studies have highlighted a role for ACKRs in neuroinflammation. However, in the CNS, the role of ACKRs seems to be more complex than the simple control of inflammation. For instance, CXCR7/ACKR3 was shown to control T cell trafficking through the regulation of CXCL12 internalization at CNS endothelial barriers. Furthermore, D6/ACKR2 KO mice were protected in a model of experimental autoimmune encephalomyelitis (EAE). D6/ACKR2 KO showed an abnormal accumulation of dendritic cells at the immunization and a subsequent impairment in T cell priming. Finally, CCRL2, an ACKR-related protein, was shown to play a role in the control of the resolution phase of EAE. Indeed, CCRL2 KO mice showed exacerbated, non-resolving disease with protracted inflammation and increased demyelination. This phenotype was associated with increased microglia and macrophage activation markers and imbalanced M1 vs. M2 polarization. This review will summarize the current knowledge on the role of the ACKRs in neuroinflammation with a particular attention to their role in microglial polarization and function.

1 July 2018 in Annals of Anatomy - Anatomischer Anzeiger
Verified
Journal Article
Closed access
EWE. Weber
E. Weber
FSF. Sozio
F. Sozio
ABA. Borghini
A. Borghini
PSPiersante Sestini
Piersante Sestini
ERE. Renzoni
E. Renzoni

1 November 2019 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
APAnnalisa Del Prete
Annalisa Del Prete
FSFrancesca Sozio
Francesca Sozio
TSTiziana Schioppa
Tiziana Schioppa
APAndrea Ponzetta
Andrea Ponzetta
WVWilliam Vermi
William Vermi
SSSilvano Sozzani
Silvano Sozzani
CCRL2 is a nonsignaling seven-transmembrane domain receptor. CCRL2 binds chemerin, a protein that promotes chemotaxis of leukocytes, including macrophages and natural killer (NK) cells. In addition, CCRL2 controls the inflammatory response in different pathologic settings, such as hypersensitivity, inflammatory arthritis, and experimental autoimmune encephalitis. Here, we investigated the role of CCRL2 in the regulation of lung cancer–related inflammation. The genetic deletion of Ccrl2 promoted tumor progression in urethane-induced and in KrasG12D/+/p53LoxP lung tumor mouse models. Similarly, a Kras-mutant lung tumor displayed enhanced growth in Ccrl2-deficient mice. This phenotype was associated with a reduced inflammatory infiltrate characterized by the impaired recruitment of several leukocyte populations including NK cells. Bone marrow chimeras showed that CCRL2 expression by the nonhematopoietic cell compartment was responsible for the increased tumor formation observed in Kras-mutant Ccrl2-deficient mice. In human and mouse lungs, CCRL2 was expressed by a fraction of CD31+ endothelial cells, where it could control NK infiltration. Elevated CCRL2 expression in biopsies from human lung adenocarcinoma positively correlated with clinical outcome. These results provide evidence for a crucial role of CCRL2 in shaping an anti–lung tumor immune response.